1Kapiteijn E,Marijnen CA,Nagtegaal ID,et al. Preoperative radiotherapy combined with to- tal mesorectal excision for resectable rectal cancer[J]. N Engl J Med,2001,345(9) :638-646.
2Mc Namara DA, Parc R. Methods and Results of Sphincter - Preserving Surgery for Rectal Cancer [ J ]. Cancer Control, 2003, 10(3) :212-218.
3Francois Y, Nemoz CJ,Baulieux J,et al. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter - sparing surgery for rectal cancer:the Lyon R90 -01 randomized trial[J]. J Clin Oncol, 1999,17 ( 8 ) :2396-2402.
4Gerard JP, Chapet O, Nemoz C, et al. improved sphincter preservation in low rectal cancer with high - dose preoperative radiotherapy:the lyon r96 -02 randomized trial [J]. J Clin Oncol,2f104,22(12):2404-2409.
5M. Marijnen CA, van de Velde C J, Putter H, et al. impact of short - term preoperative radiotherapy on health - related quality of life and sexual functioning in primary rectal cancer:report of a muhicenter randomized trial[J]. J Clin 0ncol,2005,23(9):1847-1858.
6Masi G, Loupakis F, Pollina L. Long - term outcome of initially unresectable metastatic colorectal cancer patients treated with 5 - fluorouracil/leucovofin, oxaliplatin, and irinotecan ( FOLFOXIRI ) followed by radical surgery of metastases[ J ]. Ann Surg,2009, 249 ( 3 ) :420-425.
7Chiappa A, Bertani E, Makuuchi M, et al. Neoadjuvant chemotherapy followed by hepatectomy for primarily resectable colorectal cancer liver metastases [ J ]. Hepatogastro- enterology,2009,56(91/92) :829-834.
8Deguchi Y, Endo S, Tanaka J, et al. A case or resection of synchronous multiple liver metastases from rectal cancer after FOLFOX4 therapy[J]. Gan To Kagaku Ryoho,2010,37(6) :1159-1162.
9Matsushita D, Kitazono M, Baba K. A case of advanced rectal cancer with liver and lung metastasis showing a complete response by neo - adjuvant FOLFOX4 chemotherapy[J]. Gan To Kagaku Ryoho,2010, 37( 1 ) :173-176.
10Crane CH, Skibber JM, Feig BW, et al. Response to Preoperative chemoradiation in- creases the use of sphincter - preserving surgery in patientswith locally advanced low rectal carcinoma [ J ]. cancre, 2003,2 (97) :517-524.
同被引文献32
1Tveit K, Wiig J, Olsen D, et al. Conbined modality treatment including intraoperative radiotherapy in locally advanced and recurrent rectal cancer [ J ]. Radiother Oncol, 1997,44 ( 3 ) : 277 -231.
2Folkesson J, Binrgisson H, Pahlnan L, et al. Swedish rectal cancer trial. Long lasting benefits from radiotherapy on survival and local recurrent rate[J]. J Clin Oncol,2005,23(24) :5644-5650.
3Hansen MH, Kiaeve J, Revhaug A, et al. Impact of radiotherapy on local recurrence of rectal cancer in Norway [ J ]. Br J Surg,2007,94 ( 1 ) : 113- 118.
4Gerard JP, Conroy T, Bonnetain F, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203[J]. J Clin Oncol,2006,24(28) :4620-4625.
5Francois Y, Nemoz C J, Baulieux J, et al. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial[ J]. J Clin Oncol, 1999,17 ( 8 ) :2396.
6Biekell NA, LePar F, Wang J, et al. Lost opportunities: physicians' rea - sons and disparities in breast cancer treatment. J Clin Oncol, 2007,25(18):2516-2521.
7Komenaka IK, Hsu CH, Martinez ME.Preoperative chemotherapy for operable breast cancer is associated with better compliance with ad- juvant therapy in matched stage II and IIIA patients.The Oncologist, 2011,16(6) :742-751.
8Saner R,Becker H,Hohenberger W,et al. Preoperative versus post- operative chemoradiotherapy for rectal cancer. N Engl J Med, 2004,351(17): 1731-1740.
9Park JH,Yoon SM,Yu CS ,et al. Randomized phase 3 trial compar-ing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancer. Cancer,2011,117 (16) :3703-3712.
10Fietkau R, Rodel C, Hohenberger W, et al. Rectal cancer delivery of radiotherayp in adequate time and with adequate dose is influneed by treatment center,treatment schedule,and gender and is prognostic pramenter for local control: results of study. Int J Radiat Oncol Biol Phys, 2007,67(4) : 1008-1019.
